Synergistic Apoptotic Effects of Bortezomib and Methylstat on Multiple Myeloma Cells.

In conclusion, our data suggested that bortezomib in combination with methylstat decreased cell proliferation and induced apoptosis significantly in U266 and ARH77 cells. When supported with in vivo analyses, methylstat might be considered as a potential new agent for the treatment of MM.